Skip to main content

Advertisement

Log in

TyG index and insulin resistance in beta-thalassemia

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Insulin resistance (IR) underlies some glucose metabolism abnormalities in thalassemia major. Recently, triglyceride glucose index (TyG) has been proposed for evaluating insulin resistance as a simple, low cost, and accessible tool. In this study, the TyG index were studied for IR monitoring in beta-thalassemia major (βTM) patients. The participants were 90 βTM patients on chronic regular transfusion therapy. The TyG index was computed based on fasting plasma glucose (FPG) and triglyceride (TG). The time gap between the first and the second TyG index survey (TyG.1 and TyG.2) was 2 years. The agreement between TyG and HOMA-IR were studied with the extension of limit of agreement (LOA). We included 90 patients 53.3 % men (n = 48). Among them, 14.4 % (14.6 % male, 14.3 % female) had impaired fasting glucose level (e.g., 100–125 mg/dl) at first test. It rose to 37.8 % (27.1 % male, 50 % female) during 2 years. Based on TyG.1, the 34.4 % of patients was detected as IR cases. After 2 years, the percent of IR based on TyG.2 was 82.2 %. The mean differences between TyG.1 and TyG.2 and their differences from the considered cutoff values were significant (P < 0.001). The prediction limits between TyG and HOMA-IR had good agreement. These data may suggest the use of TyG index for detection/monitoring of IR in βTM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bhat KG, Periasamy PK. Effect of long-term transfusion therapy on the glycometabolic status and pancreatic Beta cell function in patients with beta thalassemia major. J Family Med Prim Care. 2014;3(2):119–23.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Balkau B, Eschwège E. Insulin resistance: an independent risk factor for cardiovascular disease? Diabetes Obes Metab. 1999;1 Suppl 1:S23–31.

    Article  PubMed  Google Scholar 

  3. Godsland IF, Lecamwasam K, Johnston DG. A systematic evaluation of the insulin resistance syndrome as an independent risk factor for cardiovascular disease mortality and derivation of a clinical index. Metabolism. 2011;60(10):1442–8.

    Article  PubMed  CAS  Google Scholar 

  4. Kuusisto J, Lempiainen P, Mykkanen L, Laakso M. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diabetes Care. 2001;24(9):1629–33.

    Article  PubMed  CAS  Google Scholar 

  5. Hafez M, Youssry I, El-Hamed FA, Ibrahim A. Abnormal glucose tolerance in beta-thalassemia: assessment of risk factors. Hemoglobin. 2009;33(2):101–8.

    Article  PubMed  CAS  Google Scholar 

  6. Chatterjee R, Bajoria R. New concept in natural history and management of diabetes mellitus in thalassemia major. Hemoglobin. 2009;33(1):S127–30.

    Article  PubMed  CAS  Google Scholar 

  7. Borali A, Livingstone C, Kaddam I, Ferns G. Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol. 2011;11:158–68.

    Article  Google Scholar 

  8. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.

    Article  PubMed  CAS  Google Scholar 

  9. Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala MG, Hernandez-Gonzalez SO, Jacques-Camarena O, Rodriguez-Moran M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95(7):33 47–51.

  10. Abbasi F, Reaven GM. Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol. Metabolism. 2011;60(12):1673–6.

    Article  PubMed  CAS  Google Scholar 

  11. Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–100.

    Article  PubMed  CAS  Google Scholar 

  12. Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T, Tripolino C, et al. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67(7):665–72.

    Article  PubMed  CAS  Google Scholar 

  13. Petta S, Di Marco V, Di Stefano R, Cabibi D, Cammà C, Marchesini G, et al. TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. J Viral Hepat. 2011;18(7):e372–80.

    Article  PubMed  CAS  Google Scholar 

  14. Lucatello F, Vigna L, Carugno M, Tirelli AS, Bertazzi PA, Riboldi L. Comparison of indexes for assessing insulin resistance for the health surveillance among workers. G Ital Med Lav Ergon. 2012;34(3 Suppl):748–9.

    PubMed  CAS  Google Scholar 

  15. Ivovic M, Marina LV, Vujovic S, Tancic-Gajic M, Stojanovic M, Radonjic NV, et al. Nondiabetic patients with either subclinical cushing’s or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications. Metabolism. 2013;62(6):786–92.

    Article  PubMed  CAS  Google Scholar 

  16. Mericq V, Salas P, Pinto V, Cano F, Reyes L, Brown K, et al. Steroid withdrawal in pediatric kidney transplant allows better growth, lipids and body composition: a randomized controlled trial. Horm Res Paediatr. 2013;79(2):88–96.

    Article  PubMed  CAS  Google Scholar 

  17. Carstensen B. Comparing methods of measurement: extending the LoA by regression. Stat Med. 2010;29:401–10.

    Article  PubMed  Google Scholar 

  18. Bendix Carstensen, Lyle Gurrin, Claus Ekstrom and Michal Figurski. MethComp: functions for analysis of agreement in method comparison studies. 2015 R package version 1.22.2. http://CRAN.R-project.org/package=MethComp

  19. R Core Team. R: A language and environment for statistical computing. 2015 R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/.

  20. Hintze, J. PASS 11. NCSS, LLC. 2011 Kaysville, Utah, USA. www.ncss.com.

  21. Tsapas A, Vlachaki E, Christoforidis A, Sarigianni M, Bekiari E, Perifanis V, et al. Insulin sensitivity assessment with euglycemic insulin clamp in adult beta-thalassaemia major patients. Eur J Haematol. 2007;79(6):526–30.

    Article  PubMed  CAS  Google Scholar 

  22. Li MJ, Peng SS, Lu MY, Chang HH, Yang YL, Jou ST, et al. Diabetes mellitus in patients with thalassemia major. Pediatr Blood Cancer. 2014;61(1):20–4.

    Article  PubMed  Google Scholar 

  23. Ghergherehchi R, Habibzadeh A. Insulin resistance and β cell function in patients with β-thalassemia major. Hemoglobin. 2015;39(1):69–73.

    Article  PubMed  CAS  Google Scholar 

  24. Tangvarasittichai S, Pimanprom A, Choowet A, Tangvarasittichai O. Association of iron overload and oxidative stress with insulin resistance in transfusion-dependent beta-thalassemia major and beta-thalassemia/HbE patients. Clin Lab. 2013;59(7–8):861–8.

    PubMed  CAS  Google Scholar 

  25. Chern JP, Lin KH, Lu MY, Lin DT, Lin KS, Chen JD, et al. Abnormal glucose tolerance in transfusion-dependent beta thalassemic patients. Diabetes Care. 2001;24(5):850–4.

    Article  PubMed  CAS  Google Scholar 

  26. Arija V, Fernandez-Cao JC, Basora J, Bullo M, Aranda N, Estruch R, et al. Excess body iron and the risk of type 2 diabetes mellitus: a nested case-control in the PREDIMED (PREventionwith MEDiterranean Diet) study. Br J Nutr. 2014;112(11):1896–904.

    Article  PubMed  CAS  Google Scholar 

  27. De Sanctis V, Soliman A, Yassin M. Iron overload and glucose metabolism in subjects with β-thalassaemia major: an overview. Curr Diabetes Rev. 2013;9(4):332–41.

    Article  PubMed  Google Scholar 

  28. Siklar Z, Citak FE, Uysal Z, Oçal G, Ertem M, Engiz O, et al. Evaluation of glucose homeostasis in transfusion-dependent thalassemic patients. Pediatr Hematol Oncol. 2008;25(7):630–7.

    Article  PubMed  CAS  Google Scholar 

  29. Suvarna J, Ingle H, Deshmukh CT. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major. Indian Pediatr. 2006;43(5):393–400.

    PubMed  Google Scholar 

  30. Soliman AT, Yasin M, El-Awwa A, De Sanctis V. Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: pilot study. Indian J Endocrinol Metab. 2013;17(3):490–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  31. Gamberini MR, De Sanctis V, Gilli G. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the ferrara centre. Pediatr Endocrinol Rev. 2008;6 Suppl 1:158–69.

    PubMed  Google Scholar 

  32. De Sanctis V, Zurlo MG, Senesi E, Boffa C, Cavallo L, Di Gregorio F. Insulin dependent diabetes in thalassaemia. Arch Dis Child. 1988;63(1):58–62.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Mula-Abed WA, Al Hashmi H, Al Muslahi M, Al Muslahi H, Al LM. Prevalence of endocrinopathies in patients with Beta thalassaemia major—a cross-sectional study in Oman. Oman Med J. 2008;23(4):257–62.

    PubMed  PubMed Central  Google Scholar 

  34. Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping. Pediatr Diabetes. 2004;5(3):126–32.

    Article  PubMed  CAS  Google Scholar 

  35. el-Hazmi MA, al-Swailem A, al-Fawaz I, Warsey AS, al-Swailem A. Diabetes mellitus in children suffering from beta-thalassaemia. J Trop Pediatr. 1994;40(5):261–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the Golestan University of Medical Sciences for supporting the study setup. We would like to thank all the subjects for their participation and continued follow-up. The authors wish to thank all the survey personnel and the officers in Taleghani Pediatric hospital for their cooperation.

Funding

Deputy of research and technology of Golestan University of Medical Sciences

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Mehran Hosseini.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jamshir, M., Fayaz, M., Mirbehbahani, N. et al. TyG index and insulin resistance in beta-thalassemia. Int J Diabetes Dev Ctries 35 (Suppl 3), 529–534 (2015). https://doi.org/10.1007/s13410-015-0418-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-015-0418-9

Keywords

Navigation